PRLB Proto Labs Inc
Fabricated Structural Metal Products · NYSE · SEC CIK 1443669 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.8%
TTM net income YoY136.0%
TTM EPS YoY132.3%
Revenue 3-yr CAGR5.4%
Net income 3-yr CAGR—
Margins
Gross margin45.2%
Operating margin7.3%
Net margin6.0%
FCF margin8.4%
EBITDA margin12.9%
Returns
ROE5.1%
ROA4.5%
ROIC (approx.)5.5%
Asset turnover0.74x
Leverage & solvency
Liabilities / assets13.1%
Debt / equity0.00x
Current ratio3.65x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.06x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue4.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $533.13M | $500.89M |
| Cost of revenue | $295.99M | $277.69M |
| Gross profit | $237.14M | $223.20M |
| R&D expense | $42.81M | $41.30M |
| SG&A expense | $69.81M | $64.33M |
| Operating income | $25.11M | $19.91M |
| Pretax income | $31.06M | $24.67M |
| Income tax | $9.82M | $8.08M |
| Net income | $21.24M | $16.59M |
| EBITDA | $58.92M | $55.72M |
| EPS (basic) | 0.89 | 0.66 |
| EPS (diluted) | 0.88 | 0.66 |
| Weighted avg. shares (diluted) | 24.25M | 25.21M |
| Balance sheet | ||
| Cash & equivalents | $110.83M | $89.07M |
| Short-term investments | $17.30M | $14.02M |
| Receivables | $78.96M | $66.50M |
| Inventory | $14.40M | $12.30M |
| Current assets | $233.54M | $194.85M |
| PP&E, net | $215.26M | $227.26M |
| Goodwill | $273.99M | $273.99M |
| Intangibles | $18.61M | $21.42M |
| Total assets | $763.41M | $743.51M |
| Current liabilities | $67.00M | $53.27M |
| Total liabilities | $89.48M | $73.36M |
| Shareholders' equity | $673.93M | $670.15M |
| Shares outstanding | 23.63M | 24.23M |
| Cash flow statement | ||
| Operating cash flow | $74.50M | $77.83M |
| Capital expenditure | $14.84M | $9.17M |
| Free cash flow | $59.66M | $68.66M |
| Investing cash flow | -$13.41M | -$13.58M |
| Financing cash flow | -$40.37M | -$58.55M |
| Depreciation & amortization | $33.81M | $35.81M |
| Stock-based compensation | $15.73M | $17.00M |
| Share buybacks | $42.96M | $60.28M |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.